References
- Mizobuchi M, Towler D, Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol. 2009;20: 1453–1464.
- Cozzolino M, Mazzaferro S, Pugliese F, Brancaccio D. Vascular calcification and uremia: what do we know? Am J Nephrol. 2008;28: 339–346.
- Messa P. Impact of Ca/P disorders on risks and comorbidities. Contrib Nephrol. 2008;161:215–221.
- Cozzolino M, Ciceri P, Volpi EM, Olivi L, Messa PG. Pathophysiology of calcium and phosphate metabolism impairment in chronic kidney disease. BloodPurif. 2009;27:338–344.
- Burke SK. Phosphate is a uremic toxin. J Ren Nutr. 2008;18:27–32.
- Gutiérrez OM, Mannstadt M, Isakova T, et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008;359:584–592.
- Noori N, Kalantar-Zadeh K, Kovesdy CP, Bross R, Benner D, Kopple JD. Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol. 2010;5:683–692.
- Moranne O, Froissart M, Rossert J, et al. Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol. 2009;20:164–171.
- Stubbs J, Liu S, Quarles LD. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. Semin Dial. 2007;20:302–308.
- Oliveira RB, Cancela AL, Graciolli FG, et al. Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD- MBD therapy? Clin J Am Soc Nephrol. 2010;5:286–291.
- Cupisti A, D’Alessandro G. The impact of known and unknown dietary components to phosphorus intake. Giorn Ital Nefrologia. 2011;28: 278–288. Italian.
- Savica V, Calò LA, Monardo P, et al. High phosphate content beverages in dialysis patients: Relevance for hyperphosphatemia and cardiovascular risk. Nutr Metab Cardiovasc Dis. 2008;18:e39–e40.
- Kalantar-Zadeh K, Gutekunst L, Mehrotra R, et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:519–530.
- Noori N, Sims JJ, Kopple JD et al. Organic and inorganic dietary phosphorus and its management in chronic kidney disease. Iran J Kidney Dis. 2010;4:89–100.
- Di lorio B, Di Micco L, Torraca S, et al. Acute effects of very-low- protein diet on FGF23 levels: a randomized study. Clin J Am Soc Nephrol. 2012;7:581–587.
- Moe SM, Zidehsarai MP, Chambers MA, et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:257–264.
- Sullivan C, Sayre SS, Leon JB, et al. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA. 2009;301:629–635.
- Murtaugh MA, Filipowicz R, Baird BC, et al. Dietary phosphorus intake and mortality in moderate chronic kidney disease: NHANES III. Nephrol Dial Transplant. 2012;27:990–996.